戻る Agenda
Strategic Planning Across Research Organizations
Session Chair(s)
Shurjeel Choudhri
Senior Vice President and Head, Medical and Scientific Affairs
Bayer, Canada
Leveraging innovative technologies, cutting edge research, and unique capabilities are the hallmarks of robust drug discovery and development. Government organizations approach these activities differently and regional variation can also play a role in how research is conducted. Understanding these perspectives can lead to more effective collaborations. This session will give the audience insights on strategic planning and implementation of partnerships using examples from Canada, the US and the Pharma industry.
Learning Objective : Discuss how clinical research is conducted in Canada; Identify key differences that can be leveraged in executing effective collaborations.
Speaker(s)
Initiatives for Enhancing the Canadian Clinical Research Environment: A Showcase of Cross-Sectoral Collaborations
Shurjeel Choudhri
Bayer, Canada
Senior Vice President and Head, Medical and Scientific Affairs
Innovative Approaches to Getting Products to Market: The Experience in an Academic Medical Center
Bambi Grilley, RPH, RAC
Baylor College of Medicine, United States
Director, Clinical Research & Early Product Dev., Center for Cell & Gene Therapy
Industry Perspective for Strategic Collaboration
Janice Chang
TransCelerate Biopharma Inc., United States
Chief Executive Officer